Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609037 · ClinicalTrials.gov registry record
Wound Repair and Body Contouring Surgery After Gastric Bypass
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 34
- Enrollment target
NCT00609037: Completed study, sponsored by Vanderbilt University.
NCT00609037 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00609037 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The primary aim of our study is to test the hypothesis that wound healing is impaired in the patient who has experienced massive weight reduction following gastric bypass for morbid obesity. Specifically we will document post-surgical local complications and evaluate multiple wound healing parameters in two patient populations in a prospective fashion. The test group will consist of patients who have undergone dramatic weight loss and are much in need of a panniculectomy due to excessive skin redundancy. The control group will consist of patients within normal weight ranges who are seeking an abdominoplasty.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2006-01 |
| Est. Completion | 2010-03 |
What the finished NCT00609037 record still lists
NCT00609037 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00609037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00609037 about?
NCT00609037 is a clinical study titled "Wound Repair and Body Contouring Surgery After Gastric Bypass". The primary aim of our study is to test the hypothesis that wound healing is impaired in the patient who has experienced massive weight reduction following gastric bypass for morbid obesity. Specifically we will document post-surgical local complications and evaluate multiple wound healing parameter...
What is the current status of trial NCT00609037?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2006-01. Estimated completion is 2010-03.
Who is sponsoring clinical trial NCT00609037?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia